Inbunden, Engelska, 2026
Del i serien Springer Series in Healthcare Management and Innovation
De-Risking Investments in Medical Technology Innovation
Strengthening Decision-Making and Valuation Accuracy in Medical Startups
Av Luigi Negri
1589 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Beskrivning
Produktinformation
- Utgivningsdatum: 2026-04-17
- Mått: 155 x 235 x 24 mm
- Vikt: 618 g
- Format: Inbunden
- Språk: Engelska
- Serie: Springer Series in Healthcare Management and Innovation
- Antal sidor: 2
- Förlag: Springer Nature Switzerland AG
- ISBN: 9783032150066
Utforska kategorier
Mer information
Dr Luigi Negri is Founder and CEO for ThinKeen® Global Consulting (Miami, FL, USA) and Venture Partner of Obloo® Ventures Consulting (Milano, Italy). In this role, he has supported investors in the appraisal and valuation of target medical startups, he has been a board member of highly innovative medical startups and served as a member of advisory boards of broader public initiatives focused on evaluating larger populations of life science startups. In the previous twenty years, Luigi has succeeded as an executive in several international corporate assignments with general management responsibilities in the biotechnology and medical devices industry across multiple global corporations and geographical regions. These positions included VP of Northern & Central Europe for Becton Dickinson® (CR Bard), VP of Emerging Markets of Latin America at Baxter Health Care, and Area General Manager for Poland & Russian Federation at Baxter Health Care®.
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.